A strategy to deliver genes to cystic fibrosis lungs: A battle with environment

Journal of Controlled Release

Volumn 155, Issue 2, 2011, Pages 289-295

  Ibrahim, Basma M ^a   Park, Seungman ^b   Han, Bumsoo ^b,c   Yeo, Yoon ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Cystic fibrosis sputum; Gene delivery; Inhalable dry particles; Mannitol; Nanoparticles

Indexed keywords

ACTIVITY LOSS; CYSTIC FIBROSIS; CYSTIC FIBROSIS SPUTUM; GENE DELIVERY; GENE TRANSFECTION; INHALABLE DRY PARTICLES; MANNITOL; MICRO-PARTICLES; NANO PARTICULATES; PARTICLE SIZE MEASUREMENT; PULMONARY GENE DELIVERY; TRANSFER AGENTS; ENHANCED TRANSPORTS;

DRUG PRODUCTS; GENE THERAPY; GENE TRANSFER; NANOPARTICLES; GENES;

AGGLOMERATION; GENE TRANSFER;

LUCIFERASE; MANNITOL; MUCIN; NANOPARTICLE; PLASMID DNA; POLYETHYLENEIMINE; POLYSTYRENE; DNA; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CYSTIC FIBROSIS; DRUG PENETRATION; DRUG TRANSPORT; FIBROBLAST; GENE TARGETING; GENETIC TRANSFECTION; MALE; NANOENCAPSULATION; NONHUMAN; OUTCOME ASSESSMENT; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SALMON; SPUTUM; ZETA POTENTIAL; GENE; GENE TRANSFER;

ADMINISTRATION, INHALATION; ANIMALS; CROSS-LINKING REAGENTS; CYSTIC FIBROSIS; DNA; DRUG CARRIERS; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; HYALURONIC ACID; LUNG; MANNITOL; MICE; NANOPARTICLES; NIH 3T3 CELLS; PARTICLE SIZE; POLYETHYLENEIMINE; SPUTUM; TRANSFECTION;

EID: 80054121331     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.039     Document Type: Conference Paper

References (32)

1. U. Griesenbach, and E.W. Alton Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy Adv. Drug Deliv. Rev. 61 2 2009 128 139
2. R.S. Cotran, V. Kumar, T. Collins, and S.L. Robbins Robbins Pathologic Basis of Disease 1999 Saunders Philadelphia
3. M.T. Clunes, and R.C. Boucher Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis Curr. Opin. Pharmacol. 8 3 2008 292 299
4. B.K. Rubin Mucus, phlegm, and sputum in cystic fibrosis Respir. Care 54 6 2009 726 732
5. B.L. Alexander, R.R. Ali, E.W.F. Alton, J.W. Bainbridge, S. Braun, S.H. Cheng, T.R. Flotte, H.B. Gaspar, M. Grez, U. Griesenbach, M.G. Kaplitt, M.G. Ott, R. Seger, M. Simons, A.J. Thrasher, A.Z. Thrasher, and S. Yla-Herttuala Progress and prospects: gene therapy clinical trials (part 1) Gene Ther. 14 20 2007 1439 1447
6. J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, and J.L. Chou Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 245 4922 1989 1066 1073 (Pubitemid 19231814)
7. R.C. Boucher Status of gene therapy for cystic fibrosis lung disease J. Clin. Invest. 103 4 1999 441 445 (Pubitemid 29094042)
8. B.K. Rubin Mucus and mucins Otolaryngol. Clin. North Am. 43 1 2010 27 34
9. M. Proesmans, F. Vermeulen, and K. De Boeck What's new in cystic fibrosis? From treating symptoms to correction of the basic defect Eur. J. Pediatr. 167 8 2008 839 849
10. R.A. Cone Barrier properties of mucus Adv. Drug Deliv. Rev. 61 2 2009 75 85
11. C.A. Sheils, J. Kas, W. Travassos, P.G. Allen, P.A. Janmey, M.E. Wohl, and T.P. Stossel Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease Am. J. Pathol. 148 3 1996 919 927 (Pubitemid 126660683)
12. N.N. Sanders, S.C. De Smedt, E. Van Rompaey, P. Simoens, F. De Baets, and J. Demeester Cystic fibrosis sputum: a barrier to the transport of nanospheres Am. J. Respir. Crit. Care Med. 162 5 2000 1905 1911
13. J.S. Suk, S.K. Lai, Y.-Y. Wang, L.M. Ensign, P.L. Zeitlin, M.P. Boyle, and J. Hanes The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 30 13 2009 2591 2597
14. V.J. Broughton-Head, J.R. Smith, J. Shur, and J.K. Shute Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics Pulm. Pharmacol. Ther. 20 6 2007 708 717 (Pubitemid 47449753)
15. N.N. Sanders, E. Van Rompaey, S.C. De Smedt, and J. Demeester Structural alterations of gene complexes by cystic fibrosis sputum Am. J. Respir. Crit. Care Med. 164 3 2001 486 493 (Pubitemid 32778221)
16. S.L. McGill, and H.D.C. Smyth Disruption of the mucus barrier by topically applied exogenous particles Mol. Pharm. 7 6 2010 2280 2288
17. E.Y.T. Chen, Y.-C. Wang, C.-S. Chen, and W.-C. Chin Functionalized positive nanoparticles reduce mucin swelling and dispersion PLoS ONE 5 11 2010 e15434
18. S.K. Lai, D.E. O'Hanlon, S. Harrold, S.T. Man, Y.-Y. Wang, R. Cone, and J. Hanes Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U. S. A. 104 5 2007 1482 1487 (Pubitemid 46214616)
19. S.K. Lai, Y.-Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2 2009 158 171
20. B.C. Tang, M. Dawson, S.K. Lai, Y.-Y. Wang, J.S. Suk, M. Yang, P. Zeitlin, M.P. Boyle, J. Fu, and J. Hanes Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier Proc. Natl. Acad. Sci. U. S. A. 106 46 2009 19268 19273
21. M. Stern, N.J. Caplen, J.E. Browning, U. Griesenbach, F. Sorgi, L. Huang, D.C. Gruenert, C. Marriot, R.G. Crystal, D.M. Geddes, and E.W. Alton The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro Gene Ther. 5 1 1998 91 98 (Pubitemid 28045074)
22. N.N. Sanders, E. Van Rompaey, S.C. De Smedt, and J. Demeester On the transport of lipoplexes through cystic fibrosis sputum Pharm. Res. 19 4 2002 451 456 (Pubitemid 34408944)
23. http://clinicaltrials.gov/ct2/show/NCT00446680
24. http://clinicaltrials.gov/ct2/show/NCT00630812
25. Y. Yang, M.D. Tsifansky, S. Shin, Q. Lin, and Y. Yeo Mannitol-guided delivery of ciprofloxacin in artificial cystic fibrosis mucus model Biotechnol. Bioeng. 108 6 2011 1441 1449
26. P. Xu, G. Quick, and Y. Yeo Gene delivery through the use of a hyaluronate-associated intracellularly degradable cross-linked polyethyleneimine Biomaterials 30 29 2009 5834 5843
27. D.D. Sriramulu, H. Lunsdorf, S.S. Lam, and U. Romling Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung J. Med. Microbiol. 54 7 2005 667 676 (Pubitemid 40885151)
28. Y. Yang, M.D. Tsifansky, C.-J. Wu, H.I. Yang, G. Schmidt, and Y. Yeo Inhalable antibiotic delivery using a Dry powder Co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis Pharm. Res. 27 1 2010 151 160
29. J. Heyder, and M.U. Svartengren H. Bisgaard, C. O'Callaghan, G.C. Smaldone, Drug Delivery to the Lung 2002 Marcel Dekker, Inc New York 21 45
30. R. Vehring Pharmaceutical particle engineering via spray drying Pharm. Res. 25 5 2008 999 1022
31. N. Sanders, C. Rudolph, K. Braeckmans, S.C. De Smedt, and J. Demeester Extracellular barriers in respiratory gene therapy Adv. Drug Deliv. Rev. 61 2 2009 115 127
32. J.H. Jeong, S.W. Kim, and T.G. Park Molecular design of functional polymers for gene therapy Prog. Polym. Sci. 32 11 2007 1239 1274 (Pubitemid 47513188)